Industry | 2016.06.17
The Biotech Insider Trading Scandal: How Stat News Missed The Real Story - Forbes
| The Biotech Insider Trading Scandal: How Stat News Missed The Real Story Forbes Good morning all. I begin with a fan letter to Stat. Since its inception last year, Stat news impressed me with its coverage of healthcare, medical academia, and the biotech and pharmaceutical industries: good reporting, good writing, proofreading and ... |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]-trading-scandal-how-stat-news
